Beam Therapeutics

company

Number of Lead Investors

Number of Investors

Beam Therapeutics is funded by 12 investors. Casdin Capital and Cormorant Asset Management are the most recent investors.

Investor Name	Lead Investor	Funding Round
Casdin Capital	-	Post-IPO Equity
Cormorant Asset Management	-	Post-IPO Equity
Farallon Capital Management	-	Post-IPO Equity
Perceptive Advisors	-	Post-IPO Equity
Redmile Group	-	Post-IPO Equity
Altitude Life Science Ventures	-	Series B
ARCH Venture Partners	-	Series B
Eight Roads Ventures	-	Series B
F-Prime Capital	-	Series B
GV	-	Series B
Omega Funds	-	Series B
OUP (Osage University Partners)	-	Series A